Amantadine and rimantadine for preventing and treating influenza A in adults (Q24246830)

Europe PubMed Central

title

Amantadine and rimantadine for preventing and treating influenza A in adults (English)

0 references

author name string

T Jefferson

1

0 references

JJ Deeks

2

0 references

V Demicheli

3

0 references

D Rivetti

4

0 references

M Rudin

Cochrane Database of Systematic Reviews

5

0 references

publication date

19 July 2004

0 references

published in

0 references

cites work

Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Prevention of Russian Influenza by Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Trial of amantadine in epidemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Safety and pharmacokinetics of rimantadine small-particle aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Prevention of nosocomial influenza infection with Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Evaluation of amantadine in artificially induced A2 and B influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Evaluation of Therapeutic Efficacy of Amantadine in Patients With Naturally Occurring A2 Influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Rimantadine: A Clinical Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Influenza: diagnosis, management, and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

1 reference

7 January 2021

Spared an influenza pandemic for another year?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Influenza as a zoonosis: how likely is a pandemic?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Prevention of influenza A/USSR/77 (H1N1): an evaluation of the side effects and efficacy of amantadine in recruits at Fort Sam Houston

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Rimantadine prophylaxis in children: a follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Viruses and bacteria in the etiology of the common cold

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021

Protection of Man from Natural Infection with Influenza A2 Hong Kong Virus by Amantadine: A Controlled Field Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001169.PUB2

7 January 2021